We recognize and support the objectives of governments to reduce smoking rates and the associated health impacts, as well as the important role that regulation can play in achieving these objectives.
We support tobacco and nicotine regulations that is based on robust evidence, tailored to local circumstances, effectively delivers intended policy goals and avoids unintended consequences, such as the growth of illegal markets.
We believe that smokeless tobacco and nicotine products can contribute to harm reduction by providing adult smokers who would otherwise continue to smoke with alternatives to cigarettes. Although these products are not risk-free, they can offer reduced risks compared with cigarette smoking when smokers switch completely.*
To maximize this potential, smokeless products should be supported by progressive policy regimes and regulation, complemented by responsible industry practices. Regulation should be grounded in science and evidence, ensure robust product quality and safety standards, allow adult consumers to access appropriate information while preventing underage use, and provide for effective enforcement.
Our experience and expertise mean that we have much to offer governments and regulators to help to develop effective policies for cigarettes and smokeless products.
We believe collaborative dialogue between policymakers, regulators, public health authorities and the industry can support the development of effective tobacco harm reduction strategies.
For more information about BAT’s approach to progressive regulation, please visit our Global website: British American Tobacco – Progressive regulation.
* Based on the weight of evidence and assuming a complete switch from cigarette smoking. These products are not risk free and are addictive.